10th Circ. Backs Asset Freeze In SEC Case Against Biotech
The Tenth Circuit on Wednesday backed a lower court's order freezing a biotech firm's assets in a suit brought by the U.S. Securities and Exchange Commission accusing the company and its...To view the full article, register now.
Already a subscriber? Click here to view full article